PHARM.ASPHARM.ASAMS
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank82
3Y CAGR-20.2%
5Y CAGR+33.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-20.2%/yr
Quarterly compound
5Y CAGR
+33.6%/yr
Recent deceleration
Percentile
P82
Within normal range
vs 5Y Ago
4.3x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 175.13% |
| Q2 2025 | 20841.07% |
| Q1 2025 | -100.61% |
| Q4 2024 | -1.93% |
| Q3 2024 | 170.04% |
| Q2 2024 | -37.12% |
| Q1 2024 | -182.38% |
| Q4 2023 | 250.64% |
| Q3 2023 | 132.53% |
| Q2 2023 | 54.82% |
| Q1 2023 | -529.18% |
| Q4 2022 | -57.17% |
| Q3 2022 | 344.48% |
| Q2 2022 | 1102.99% |
| Q1 2022 | -97.20% |
| Q4 2021 | 0.00% |
| Q2 2021 | 15.84% |
| Q1 2021 | -82.46% |
| Q4 2020 | 33.11% |
| Q3 2020 | -16.47% |
| Q2 2020 | 41.16% |
| Q1 2020 | -26.25% |
| Q4 2019 | 539.94% |
| Q3 2019 | -80.46% |
| Q2 2019 | 44.71% |
| Q1 2019 | -32.15% |
| Q4 2018 | -6.18% |
| Q3 2018 | 54.66% |
| Q2 2018 | 586.80% |
| Q1 2018 | -107.55% |
| Q4 2017 | 88.74% |
| Q3 2017 | 1703.83% |
| Q2 2017 | 83.96% |
| Q1 2017 | -356.12% |
| Q4 2016 | 158.26% |
| Q3 2016 | 39.25% |
| Q2 2016 | -88.61% |
| Q1 2016 | -4.13% |
| Q4 2015 | 33.36% |
| Q3 2015 | 11.23% |